Key Financial Data Of Reporting Company

Daito Pharmaceutical Co., Ltd. - Filing #7341852

Concept 2023-06-01 to
2024-02-29
As at
2024-02-29
2023-12-01 to
2024-02-29
As at
2023-05-31
2022-06-01 to
2023-05-31
As at
2023-02-28
2022-12-01 to
2023-02-28
2022-06-01 to
2023-02-28
Key financial data of reporting company
Business results of reporting company
Net sales
34,662,000,000 JPY
45,101,000,000 JPY
34,570,000,000 JPY
Ordinary profit (loss)
3,122,000,000 JPY
5,169,000,000 JPY
4,077,000,000 JPY
Net assets
52,045,000,000 JPY
50,971,000,000 JPY
49,851,000,000 JPY
Total assets
77,351,000,000 JPY
70,552,000,000 JPY
68,602,000,000 JPY
Basic earnings (loss) per share
148.35
50.13
227.63
56.83
168.16
Diluted earnings per share
227.42
167.96
Equity-to-asset ratio
0.670 xbrli:pure
0.718 xbrli:pure
0.722 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.